FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

5336511000001104: Co-amoxiclav 500mg/125mg tablets 12 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
23062501000001115 Co-amoxiclav 500mg/125mg tablets 12 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
23062601000001116 Co-amoxiclav 500mg/125mg tablets 12 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

7 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Co-amoxiclav 500mg/125mg tablets 12 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Co-amoxiclav 500mg/125mg tablets 12 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Co-amoxiclav 500mg/125mg tablets 12 tablet Has VMP Co-amoxiclav 500mg/125mg tablets true Inferred relationship Existential restriction modifier
Co-amoxiclav 500mg/125mg tablets 12 tablet Has VMP Co-amoxiclav 500mg/125mg tablets false Inferred relationship Existential restriction modifier
Co-amoxiclav 500mg/125mg tablets 12 tablet Is pack of Product containing precisely amoxicillin 500 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Co-amoxiclav 500mg/125mg tablets 12 tablet Has active ingredient Amoxicillin trihydrate false Inferred relationship Existential restriction modifier
Co-amoxiclav 500mg/125mg tablets 12 tablet Has active ingredient Amoxicillin false Inferred relationship Existential restriction modifier
Co-amoxiclav 500mg/125mg tablets 12 tablet Has active ingredient Clavulanate potassium false Inferred relationship Existential restriction modifier
Co-amoxiclav 500mg/125mg tablets 12 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Co-amoxiclav 500mg/125mg tablets 12 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Co-amoxiclav 500mg/125mg tablets 12 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Co-amoxiclav 500mg/125mg tablets 12 tablet Has VMP Product containing precisely amoxicillin 500 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Co-amoxiclav 500mg/125mg tablets 12 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Clavulanic acid true Inferred relationship Existential restriction modifier
Co-amoxiclav 500mg/125mg tablets 12 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Amoxicillin true Inferred relationship Existential restriction modifier
Co-amoxiclav 500mg/125mg tablets 12 tablet Has specific active ingredient Clavulanate potassium true Inferred relationship Existential restriction modifier
Co-amoxiclav 500mg/125mg tablets 12 tablet Has specific active ingredient Amoxicillin trihydrate true Inferred relationship Existential restriction modifier
Co-amoxiclav 500mg/125mg tablets 12 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Co-amoxiclav 500mg/125mg tablets 12 tablet Has basis of strength substance Clavulanic acid true Inferred relationship Existential restriction modifier
Co-amoxiclav 500mg/125mg tablets 12 tablet Has basis of strength substance Amoxicillin true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Augmentin 625mg tablets (PI) (Waymade Ltd) 12 tablet 3 x 4 tablets Is a True Co-amoxiclav 500mg/125mg tablets 12 tablet Inferred relationship Existential restriction modifier
Augmentin 625mg tablets (PI) (Dowelhurst Ltd) 12 tablet 3 x 4 tablets Is a True Co-amoxiclav 500mg/125mg tablets 12 tablet Inferred relationship Existential restriction modifier
Co-amoxiclav 500mg/125mg tablets (PI) (Dowelhurst Ltd) 12 tablet 3 x 4 tablets Is a True Co-amoxiclav 500mg/125mg tablets 12 tablet Inferred relationship Existential restriction modifier
Augmentin 625mg tablets (Doncaster Pharmaceuticals Ltd) 12 tablet Is a True Co-amoxiclav 500mg/125mg tablets 12 tablet Inferred relationship Existential restriction modifier
Augmentin 625mg tablets (Sigma Pharmaceuticals Plc) 12 tablet Is a True Co-amoxiclav 500mg/125mg tablets 12 tablet Inferred relationship Existential restriction modifier
Augmentin 625mg tablets (Lexon (UK) Ltd) 12 tablet Is a True Co-amoxiclav 500mg/125mg tablets 12 tablet Inferred relationship Existential restriction modifier
Augmentin 625mg tablets (Mawdsley-Brooks & Company Ltd) 12 tablet Is a True Co-amoxiclav 500mg/125mg tablets 12 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start